Archived on: September 1, 2011. This document may contain dated information. It remains available to provide access to historical materials.
This assessment is an outgrowth of a partnership between the NDIC and HIDTA Program for preparation of annual assessments depicting drug trafficking trends and developments in HIDTA Program areas. The report has been coordinated with the HIDTA, is limited in scope to HIDTA jurisdictional boundaries, and draws upon a wide variety of sources within those boundaries.
Your questions, comments, and suggestions for future subjects are welcome at any time. Addresses are provided at the end of the page.
Figure 1. Lake County High Intensity Drug Trafficking Area
Individuals Receiving Drug Abuse Treatment Services in Lake
County Through the Hoosier Assurance Plan, by Drug, 2005-2009
Table 2. Percentage of Twelfth-Grade Students Reporting Lifetime Drug Use, by Drug, Northwest Region of Indiana, Compared With Statewide Data, 2009
The distribution and abuse of crack cocaine and heroin are the primary drug threats to the Lake County High Intensity Drug Trafficking Area (HIDTA) region. The following are significant strategic drug threat developments in the region:
To Top To Contents
National Drug Intelligence Center
319 Washington Street, 5th Floor
Johnstown, PA 15901-1622
Tel. (814) 532-4601
FAX (814) 532-4690
Office of Policy and Interagency Affairs
U.S. Department of Justice
Robert F. Kennedy Building, Room 3341
950 Pennsylvania Avenue, NW
Washington, D.C. 20530-2000
Telephone: (202) 532-4040
FAX (202) 514-4252
a. Opioid pain relievers include codeine, fentanyl (Duragesic, Actiq), hydromorphone (Dilaudid), meperidine (Demerol), morphine (MS Contin), oxycodone (OxyContin, Roxicodone), methadone (Dolophine), and hydrocodone combinations (Vicodin, Lortab, and Lorcet).
End of page.